Latest Breaking News On - சிஸ் - Page 14 : comparemela.com

Synopsis In Russia, allergic rhinitis affects 10-20 per cent of the population on average, with certain regions having a higher prevalence rate of 18-38 per cent. Allergic rhinitis can impact a person s quality of life and lead to functional impairments, as well as increase the risk of having asthma, the company said. Agencies Representative Image Glenmark Pharma on Monday its Swiss subsidiary has received marketing approval from the Russian health regulator for its nasal spray Ryaltris. Ryaltris is indicated for symptomatic treatment of seasonal and perennial allergic rhinitis in adults and children over 12 years of age. The drug relieves symptoms of allergic rhinitis, including stuffy nose, runny nose, nasal itching, sneezing, as well as itchy, red and watery eyes.

Russian federationGlenmark pharmaMinistry of health the russian federationGlenmark pharmaceuticalsRyaltris nasal sprayKantor senior vice presidentNasal sprayAllergic rhinitisரஷ்ய கூட்டமைப்புக்ளேண்மர்க் பார்மாஅமைச்சகம் ஆஃப் ஆரோக்கியம் தி ரஷ்ய கூட்டமைப்புக்ளேண்மர்க் மருந்துகள்க்யாஂடர் மூத்தவர் துணை ப்ரெஸிடெஂட்நாசி தெளிப்பு